三联神经保护下急诊颈动脉内膜剥脱术治疗超时间窗急性卒中安全性的初步研究
本研究评估了三联神经保护(靶向低温、控制性高血压和巴比妥类药物脑抑制)在超出tPA时间窗的急性卒中患者急诊颈动脉内膜剥脱术中的初步安全性。25例患者接受急诊CEA,术后无心肌梗死、死亡、颅神经损伤等严重不良事件,80%出院时Rankin评分为0,88%出院回家。结论认为三联神经保护可带来良好神经结局,但阳性结果可能难以在非高容量中心复制。
要点
- 三联神经保护用于超时间窗急性卒中急诊CEA未观察到严重不良事件。
- 80%患者出院时Rankin评分为0,88%出院回家。
- 阳性结果可能仅在高容量中心可复制,需转诊至经验丰富中心。
核心结论
- 三联神经保护在急诊CEA治疗急性脑损伤患者中观察到良好神经结局且无严重不良事件。
- 推荐对围术期卒中风险增加或已发生急性卒中超过24小时推荐窗口的患者使用三联神经保护。
- 阳性结局可能难以在高容量中心之外复制,需将患者转诊至有经验的三级转诊中心。
研究设计与样本
- 回顾性研究,2015年3月至2019年期间共25例急性密集卒中患者接受急诊CEA。
- 25例患者中60%有偏侧忽视且MRI显示急性梗死,Rankin评分为4或5。
主要发现
- 无心肌梗死、死亡、颅神经损伤、伤口血肿或手术出血病例。
- 平均住院时间为8.4(±9.5)天。
- 除3例既往溶栓失败者外,所有病例神经系统症状均缓解。
- 80%患者出院时Rankin评分为0,88%患者出院回家,3例需康复治疗。
关键数值与推荐
- 三联神经保护包括治疗性诱导低温(32-34°C)、目标高血压(收缩压180-200 mm Hg)和巴比妥类药物脑抑制。
- 推荐对围术期卒中风险增加或急性卒中超过24小时推荐窗口的患者使用三联神经保护。
临床怎么用
- 对于超出tPA时间窗的急性卒中合并颈动脉狭窄患者,可考虑在急诊CEA中应用三联神经保护。
- 此类手术应在高容量中心由经验丰富的外科医生进行,患者应转诊至适当的三级转诊中心。
局限性
- 样本量小(25例),为初步安全性研究。
- 阳性结果可能难以在高容量中心之外复制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The aim of this study is to establish the initial safety of triple neuroprotection (TNP) in an acute stroke setting in patients presenting outside the window for systemic tissue plasminogen activator (tPA). METHODS: Over 12,000 patients were referred to our vascular services with carotid artery disease, of whom 832 had carotid intervention with a stroke rate of 0.72%. Of these, 25 patients presented (3%), between March 2015 and 2019, with acute dense stroke. These patients had either failed tPA or passed the recommended timing for acute stroke intervention. Fifteen (60%) had hemi-neglect with evidence of acute infarct on magnetic resonance imaging of the brain and a Rankin score of 4 or 5. Ninety-six percent had an 80-99% stenosis on the symptomatic side. Mean ABCD3-I score was 11.35. All patients underwent emergency carotid endarterectomy (CEA) with therapeutically induced hypothermia (32-34°C), targeted hypertension (systolic blood pressure 180-200 mm Hg), and brain suppression with barbiturate. RESULTS: There were no cases of myocardial infarction, death, cranial nerve injury, wound hematoma, or procedural bleeding. Mean hospital stay was 8.4 (±9.5) days. All cases had resolution of neurological symptoms, except 3 who had failed previous thrombolysis. Eighty percent had a postoperative Rankin score of 0 on discharge and 88% of patients were discharged home with 3 requiring rehabilitation. CONCLUSIONS: Positive neurological outcomes and no serious adverse events were observed using TNP during emergency CEA in patients with acute brain injury. We recommend TNP for patients who are at an increased risk of stroke perioperatively, or who have already suffered from an acute stroke beyond the recommended window of 24 hr. Certainly, the positive outcomes are not likely reproducible outside of high-volume units and patients requiring this surgery should be transferred to experienced surgeons in appropriate tertiary referral centers.
引用
- Sultan S, Dulai M, Laffey J, et al. Safety of Triple Neuroprotection with Targeted Hypothermia, Controlled Induced Hypertension, and Barbiturate Infusion during Emergency Carotid Endarterectomy for Acute Stroke after Missing the 24 Hours Window Opportunity. Ann Vasc Surg. 2020. PMID: 32473308. doi:10.1016/j.avsg.2020.05.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。